<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To review the potential role of leptin, hyperleptinaemia and leptin resistance in the cardiovascular and <z:chebi fb="32" ids="24621">endocrine</z:chebi> complications of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Review of literature listed in Medline </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Hyperleptinaemia is common in <z:hpo ids='HP_0001513'>obesity</z:hpo> and reflects <z:mp ids='MP_0010024'>increased adiposity</z:mp> and leptin resistance </plain></SENT>
<SENT sid="3" pm="."><plain>Nevertheless, leptin resistance may not be complete as several actions of leptin, such as cardiovascular sympatho-activation, might be preserved in <z:mp ids='MP_0001261'>obese</z:mp> subjects known to be resistant to the metabolic effects of leptin (i.e. selective leptin resistance) </plain></SENT>
<SENT sid="4" pm="."><plain>Notably, the renal and sympathetic actions of leptin may play an important role in the pathogenesis of <z:hpo ids='HP_0000822'>hypertension</z:hpo> related to <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the lipotoxic effect of leptin resistance may cause <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo>, increasing the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Leptin has also been shown to possess proliferative, pro-inflammatory, pro-thrombotic, and pro-oxidative actions </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Hyperleptinaemia and leptin resistance may contribute to <z:hpo ids='HP_0000822'>hypertension</z:hpo>, impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, and pro-atherogenic state in <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>